Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Abl Y170-p
CDK3 S63-p , S73-p
CK2A1 T231-p
ERK1 S63-p , S73-p
ERK2 S63-p , S73-p
ERK7 S63-p , S73-p
JNK1 S63-p , S73-p , T91-p , T93-p
JNK2 S63-p
PAK2 T2-p , T8-p , T89-p , T93-p , T286-p
PBK S63-p , S73-p
PLK3 S63-p , S73-p
VRK1 S63-p , S73-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK3 S63-p , S73-p
CK2A1 T231-p , S243-p , S249-p
ERK1 S63-p , S73-p
ERK2 S63-p , S73-p
ERK7 S63-p , S73-p
GSK3B T239-p , S243-p
JNK1 S63-p , S73-p
JNK2 S63-p , S73-p
PAK2 T2-p , T8-p , T89-p , T93-p , T286-p
PBK S63-p , S73-p
PRKD1 S63-p
VRK1 S63-p , S73-p
Phosphatases, in vitro:
PPP2CA S63-p , S73-p
PPP2R2A T239-p
PPP3CA S243-p
PPP5C S63-p
Putative upstream phosphatases:
PPP2R2A T239-p
Regulatory protein:
BMF S73-p
CDCA4 S63-p , S73-p
CDK3 S63-p , S73-p
FAT S63-p
FBXW7 S63-p , T239-p
HER4 S63-p , S73-p
HRas S63-p , S73-p
Jun T239-p , S243-p
LKB1 S63-p , S73-p
Lyric K268-ac , K271-ac , K273-ac
MEKK1 S63-p , S73-p
MST2 S73-p
NFkB-p100 S73-p
plakophilin 2 S63-p
PPP3CA S63-p , S243-p
PRKD1 S63-p , S73-p
PRP4 S63-p
PRR7 S63-p , S73-p
RACK1 S63-p
RALA S63-p , S73-p
ROCK1 S63-p , S73-p
TBK1 S63-p
XIAP S63-p , S73-p
Treatment:
15d-PGJ2 S63-p
2-deoxyglucose S243-p
4-HT S73-p , T91-p , T93-p
adriamycin S73-p
AG1478 S63-p , S73-p , T91-p , T93-p
angiotensin_2 S63-p , S73-p
anisomycin S63-p , T91-p , T93-p , T239-p , S243-p
anti-CD3 S63-p
anti-TCR S63-p , S73-p
arsenite S63-p
beta-glycerophosphate S63-p , S73-p
Boc-D-FMK S63-p
bortezomib S63-p
bryostatin_1 S63-p , S73-p
BSO S73-p
caffeine T91-p , T93-p
CCT007093 S73-p
Cd(2+) S63-p , S73-p
CHIR99021 S63-p
cisplatin S63-p
cobalt S63-p , S73-p
cycloheximide S63-p , T239-p
dasatinib S73-p
DCVC S63-p
EGF T2-p , T8-p , S63-p , S73-p , T89-p , T93-p , T286-p
EKI-785 S63-p , S73-p
etoposide S63-p , S73-p , T91-p , T93-p
faslodex S73-p , T91-p , T93-p
FGF1 S63-p
hepatitis C virus expression S63-p
hypoxia S63-p , S73-p
hypoxia/reoxygenation S63-p , S73-p
IL-1a S63-p , S73-p
insulin S63-p
ionizing_radiation S63-p , S73-p
ischemia T62-p , S73-p
JNK_inhibitor_I S63-p , S73-p
JNK_inhibitor_VII S63-p
kainic_acid S63-p , S73-p
lapatinib S73-p
low_glucose S63-p
LY294002 S63-p , S73-p
metastatic potential S73-p
MMS S63-p , S73-p
NAC S73-p
neurotensin S63-p
NGF_withdrawal S63-p
nocodazole S63-p , S73-p
okadaic_acid S63-p , S73-p , T239-p
PD98059 S63-p , S73-p , T91-p , T93-p , T239-p , S243-p
phorbol_ester S63-p , S73-p , T91-p , T93-p , T239-p , S243-p
plasmin S63-p
PLX4720 S73-p
rapamycin S63-p
SB203580 S63-p , S73-p
selumetinib S63-p
serum S63-p , S73-p
serum_withdrawal S63-p , S73-p
SII_angiotensin_2 S63-p , S73-p
siRNA S63-p , S73-p
SNP S63-p , S73-p
SP600125 S63-p , S73-p , T91-p , T93-p
staurosporine S63-p
TAK1_inhibitor S73-p
TNF S73-p
U0126 S63-p , S73-p
UV S63-p , S73-p , T91-p , T93-p
vemurafenib T62-p , S63-p , S73-p
WR1065 S73-p
Y27632 S63-p , S73-p